JPH09503125A - 組み換えクラドスポリウムヘルバルム(Cladosporiumherbarum)アレルゲン - Google Patents
組み換えクラドスポリウムヘルバルム(Cladosporiumherbarum)アレルゲンInfo
- Publication number
- JPH09503125A JPH09503125A JP7507225A JP50722595A JPH09503125A JP H09503125 A JPH09503125 A JP H09503125A JP 7507225 A JP7507225 A JP 7507225A JP 50722595 A JP50722595 A JP 50722595A JP H09503125 A JPH09503125 A JP H09503125A
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- recombinant
- protein
- sequences
- polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Burglar Alarm Systems (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.配列16や17と同様に配列1、3−5、7−9、12−14もしくはこれ らの配列の部分領域と相同的に適合する核酸配列を有する、または緊縮条件で該 核酸配列とハイブリダイズする核酸配列を持っていることを特徴とする、アレル ゲンClah53、Clah47、Clah22およびClah11の抗原性を 有するポリペプチド、又はこれらのアレルゲンの少なくとも1つのエピトープを 有するペプチドをコードする組み換えDNA分子。 2.配列16や17と同様に前記配列1、3−5、7−9、12−14から変性 (縮重)によって誘導することができる核酸配列を有することを特徴とするクレ ーム1に記載の組み換えDNA分子。 3.抗原としてアレルゲンClah53、Clah47、Clah22およびC lah11と交差反応性があり、これらと高い相同性を示すポリペプチドをコー ドする核酸配列を有することを特徴とするクレーム1または2に記載の組み換え DNA分子。 4.発現構成を付与する発現調節配列と機能的に結合されていることを特徴とす るクレーム1〜3に記載の組み換えDNA分子。 5.クレーム4に記載の組み換え発現構成で形質転換されることを特徴とするポ リ ペプチドの発現のための宿主系。 6.Clah53、Clah47、Clah22若しくはClah11又はこれ らのタンパク質の少なくとも1つのエピトープの抗原性を有することを特徴とす るクレーム1〜3のいずれかに記載のDNA由来の組み換え又は合成によるタン パク質又はポリペプチド。 7.配列16や17と同様に前記配列1、3−5、7−9、12−14と完全に または部分的に対応するアミノ酸配列を有することを特徴とするクレーム6に記 載の組み換え又は合成によるタンパク質又はポリペプチド。 8.アレルゲンClah53、Clah47、Clah22若しくはClah1 1又はこれらの少なくとも1つのエピトープの抗原性と付加的ポリペプチド部分 を有する融合産物、 クレーム4に記載の発現構成のDNAによりコードされている融合産物全体、 から構成されることを特徴とするクレーム6または7のいずれかに記載の組み換 え又は合成によるタンパク質又はポリペプチド。 9.前記付加ポリペプチド部分がβ−ガラクトシダーゼ又は他の融合に適したポ リペプチドであることを特徴とするクレーム8に記載の組み換え又は合成による タンパク質又はポリペプチド。 10.クレーム6〜9のいずれかに記載の合成によるタンパク質又はポリペプチ ドを含有していることを特徴とする診断または治療用試薬。 11.患者の血清中のIgE抗体とクレーム6〜9のいずれかに記載の組み換え 又は合成によるタンパク質又はポリペプチドとの反応を測定することを特徴とす るアレルゲンClah53、Clah47、Clah22又はClah11に対 する患者のアレルギーをインビトロで検出する方法。 12.クレーム6〜9のいずれかに記載の組み換え又は合成によるタンパク質又 はポリペプチドが細胞反応の刺激又は阻害に使用されることを特徴とするアレル ゲンClah53、Clah47、Clah22又はClah11に対する細胞 反応をインビトロで検出する方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT0172593A AT400722B (de) | 1993-08-27 | 1993-08-27 | Rekombinante cladosporium herbarum allergene |
AT1725/93 | 1993-08-27 | ||
PCT/AT1994/000120 WO1995006121A2 (de) | 1993-08-27 | 1994-08-24 | Rekombinante chladosporium herbarum allergene |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH09503125A true JPH09503125A (ja) | 1997-03-31 |
JP3758671B2 JP3758671B2 (ja) | 2006-03-22 |
Family
ID=3519665
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP50722595A Expired - Lifetime JP3758671B2 (ja) | 1993-08-27 | 1994-08-24 | 組み換えクラドスポリウムヘルバルム(Cladosporiumherbarum)アレルゲン |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0714441B1 (ja) |
JP (1) | JP3758671B2 (ja) |
AT (2) | AT400722B (ja) |
AU (1) | AU7357294A (ja) |
CA (1) | CA2170356A1 (ja) |
DE (1) | DE59410221D1 (ja) |
DK (1) | DK0714441T3 (ja) |
ES (1) | ES2191033T3 (ja) |
FI (1) | FI960881A (ja) |
NO (1) | NO960749L (ja) |
PT (1) | PT714441E (ja) |
WO (1) | WO1995006121A2 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2011501669A (ja) * | 2007-10-18 | 2011-01-13 | セル・シグナリング・テクノロジー・インコーポレイテツド | ヒト非小細胞肺癌における転座および変異rosキナーゼ |
JP2015520171A (ja) * | 2012-06-01 | 2015-07-16 | サーカッシア リミテッド | クラドスポリウムペプチド |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPM473294A0 (en) * | 1994-03-25 | 1994-04-21 | Franklyn, Kathleen Mary | Peptides for diagnostics and therapeutics |
AT403166B (de) * | 1995-03-02 | 1997-11-25 | Biomay Prod & Handel | Rekombinante dna moleküle, die für polypeptide kodieren, die die antigenität der allergene clah8 und clah12 besitzen |
US6538177B1 (en) | 1998-07-15 | 2003-03-25 | Pioneer Hi-Bred International, Inc. | Compositions and methods for fumonisin detoxification |
US6388171B1 (en) | 1999-07-12 | 2002-05-14 | Pioneer Hi-Bred International, Inc. | Compositions and methods for fumonisin detoxification |
AU5099699A (en) * | 1999-07-14 | 2001-02-05 | Curagen Corporation | Compositions and methods for fumonisin detoxification |
CN108732284B (zh) * | 2018-06-04 | 2021-01-12 | 山东出入境检验检疫局检验检疫技术中心 | 一种使用专属性肽段组鉴别对虾的方法 |
-
1993
- 1993-08-27 AT AT0172593A patent/AT400722B/de not_active IP Right Cessation
-
1994
- 1994-08-24 AT AT94923586T patent/ATE229074T1/de not_active IP Right Cessation
- 1994-08-24 AU AU73572/94A patent/AU7357294A/en not_active Abandoned
- 1994-08-24 CA CA002170356A patent/CA2170356A1/en not_active Abandoned
- 1994-08-24 PT PT94923586T patent/PT714441E/pt unknown
- 1994-08-24 ES ES94923586T patent/ES2191033T3/es not_active Expired - Lifetime
- 1994-08-24 EP EP94923586A patent/EP0714441B1/de not_active Expired - Lifetime
- 1994-08-24 DK DK94923586T patent/DK0714441T3/da active
- 1994-08-24 JP JP50722595A patent/JP3758671B2/ja not_active Expired - Lifetime
- 1994-08-24 WO PCT/AT1994/000120 patent/WO1995006121A2/de active IP Right Grant
- 1994-08-24 DE DE59410221T patent/DE59410221D1/de not_active Expired - Lifetime
-
1996
- 1996-02-23 NO NO960749A patent/NO960749L/no unknown
- 1996-02-26 FI FI960881A patent/FI960881A/fi not_active Application Discontinuation
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2011501669A (ja) * | 2007-10-18 | 2011-01-13 | セル・シグナリング・テクノロジー・インコーポレイテツド | ヒト非小細胞肺癌における転座および変異rosキナーゼ |
US9096855B2 (en) | 2007-10-18 | 2015-08-04 | Cell Signaling Technology, Inc. | Translocation and mutant ROS kinase in human non-small cell lung carcinoma |
US9328349B2 (en) | 2007-10-18 | 2016-05-03 | Cell Signaling Technology, Inc. | Translocation and mutant ROS kinase in human non-small cell lung carcinoma |
US10526661B2 (en) | 2007-10-18 | 2020-01-07 | Cell Signaling Technology, Inc. | Translocation and mutant ROS kinase in human non-small cell lung carcinoma |
JP2015520171A (ja) * | 2012-06-01 | 2015-07-16 | サーカッシア リミテッド | クラドスポリウムペプチド |
Also Published As
Publication number | Publication date |
---|---|
ATA172593A (de) | 1995-07-15 |
DE59410221D1 (de) | 2003-01-16 |
NO960749D0 (no) | 1996-02-23 |
WO1995006121A2 (de) | 1995-03-02 |
FI960881A (fi) | 1996-04-25 |
FI960881A0 (fi) | 1996-02-26 |
EP0714441A1 (de) | 1996-06-05 |
JP3758671B2 (ja) | 2006-03-22 |
AT400722B (de) | 1996-03-25 |
EP0714441B1 (de) | 2002-12-04 |
CA2170356A1 (en) | 1995-03-02 |
NO960749L (no) | 1996-04-24 |
PT714441E (pt) | 2003-04-30 |
DK0714441T3 (da) | 2003-03-24 |
AU7357294A (en) | 1995-03-21 |
ATE229074T1 (de) | 2002-12-15 |
WO1995006121A3 (de) | 1995-07-13 |
ES2191033T3 (es) | 2003-09-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Swoboda et al. | Mutants of the major ryegrass pollen allergen, Lol p 5, with reduced IgE‐binding capacity: candidates for grass pollen‐specific immunotherapy | |
Banerjee et al. | Immunological characterization of Asp f 2, a major allergen from Aspergillus fumigatus associated with allergic bronchopulmonary aspergillosis | |
Kurup et al. | Fungal allergens and peptide epitopes☆ | |
Banerjee et al. | Molecular cloning and expression of a recombinant Aspergillus fumigatus protein Asp f II with significant immunoglobulin E reactivity in allergic bronchopulmonary aspergillosis | |
CN101825637B (zh) | 用于免疫诊断1型糖尿病的组合物 | |
US20110150920A1 (en) | Allergy Vaccines Containing Hybrid Polypeptides | |
Banerjee et al. | Conformational and linear B-cell epitopes of Asp f 2, a major allergen of Aspergillus fumigatus, bind differently to immunoglobulin E antibody in the sera of allergic bronchopulmonary aspergillosis patients | |
Ortona et al. | Molecular and immunological characterization of the C‐terminal region of a new Echinococcus granulosus Heat Shock Protein 70 | |
KR100271417B1 (ko) | 재조합 펩티드 | |
Mossabeb et al. | Characterization of a novel isoform of α-nascent polypeptide-associated complex as IgE-defined autoantigen | |
JPH09503125A (ja) | 組み換えクラドスポリウムヘルバルム(Cladosporiumherbarum)アレルゲン | |
US20150210742A1 (en) | Novel allergen from ragweed pollen and uses thereof | |
JP3220451B2 (ja) | ブタクサからのアレルゲン蛋白質およびそれらの使用 | |
Brander et al. | IgE-binding proliferative responses and skin test reactivity to Cop c 1, the first recombinant allergen from the basidiomycete Coprinus comatus | |
KR100465382B1 (ko) | 말라세지아에서 유래된 항원성 단백질 | |
Tsai et al. | Molecular cloning and characterization of full‐length cDNAs encoding a novel high‐molecular‐weight Dermatophagoides pteronyssinus mite allergen, Der p 11 | |
JP2011041566A (ja) | 低減したアレルギー誘発性および保持されたT細胞反応性を有するPhlp5a誘導体 | |
Banerjee et al. | Molecular biology of Aspergillus allergens | |
Tang et al. | cDNA cloning and immunologic characterization of a novel EF‐1β allergen from Penicillium citrinum | |
JPH09503654A (ja) | 組み換えアルタナリアアルタネイタ(Alternariaalternata)アレルゲン | |
Lee et al. | Identification of immunoglobulin E (IgE)-binding epitopes and recombinant IgE reactivities of a latex cross-reacting Indian jujube Ziz m 1 allergen | |
JP4686710B2 (ja) | スギ花粉由来の新規アレルゲンおよびその利用 | |
Althaus et al. | Cloning and sequencing of a cDNA expressing a ribosomal P0 peptide from Culicoides nubeculosus (Diptera) | |
Kurup et al. | Molecular biology and immunology of fungal allergens | |
CN101125884A (zh) | 一种多肽及其编码基因与应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20050531 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050812 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20051129 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20051227 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100113 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110113 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120113 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120113 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130113 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140113 Year of fee payment: 8 |
|
EXPY | Cancellation because of completion of term |